Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$21.2

Avg closing price
Price range

11 Ken Griffin Calliditas Therapeutics AB Trades

The first Calliditas Therapeutics AB trade was made in Q2 2020. Since then Ken Griffin bought shares five more times and sold shares on five occasions. The investor sold all their shares in Q2 2024 and doesn't own any shares in Calliditas Therapeutics AB anymore.

Avg closing price
Price range
Sold -14.6 Thousand shares Q2 2024
Avg closing price $27.10
Price range $17.55 - $41.41
Increased shares by 1664.7% (+13.8 Thousand shares) Q1 2024
Avg closing price $22.24
Price range $20.04 - $25.66
Sold 83.3% shares (-4.13 Thousand shares) Q4 2023
Avg closing price $18.72
Price range $15.79 - $28.99
Increased shares by 330.0% (+3.81 Thousand shares) Q3 2023
Avg closing price $17.30
Price range $15.68 - $20.38
New holding (+1.15 Thousand shares) Q2 2023
Avg closing price $21.10
Price range $15.70 - $25.61
Sold -763 shares Q1 2023
Avg closing price $19.98
Price range $16.80 - $25.24
New holding (+763 shares) Q4 2022
Avg closing price $16.13
Price range $11.50 - $19.60
Sold -9.57 Thousand shares Q2 2021
Avg closing price $28.61
Price range $26.02 - $31.18
New holding (+9.57 Thousand shares) Q1 2021
Avg closing price $29.88
Price range $27.01 - $32.92
Sold -63.6 Thousand shares Q3 2020
Avg closing price $23.30
Price range $21.61 - $25.69
New holding (+63.6 Thousand shares) Q2 2020
Avg closing price $19.81
Price range $19.17 - $23.20

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!